This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Study: Random Drug Testing Of Middle School Students Proves Effective In Preventing Substance Abuse

Researchers – who are in no way affiliated with the program being studied – weren't expecting these results.  Research on the effect of random drug testing in high schools, or among athletes, has been mixed, and  indicated that the most likely effects would come from students being less likely to use drugs because of fear that they'd be tested in the future, or from increased knowledge about how many of their peers were using drugs.

"People expect students to say, 'I'm not going to do drugs now because I might be tested tomorrow,' but that's just not how kids and teenagers think," said Cassino. "What seems to be happening is that students who've been tested start to realize what a big deal it is, and stay away from drugs in the future."  The results also indicate that drug and alcohol use in middle school is relatively rare. For instance, only about 1 percent of 8 th graders give answers that indicate that they have ever used illicit drugs, and only about 14 percent indicate that they have ever drunk alcohol (other than in circumstances where it's allowed, such as religious ceremonies). Among students who were tested for drugs and alcohol at some point, though, that figure of 14 percent drops by more than half to 6 percent.

The study surveyed more than 3,500 students at New Jersey middle and high schools over a seven year period. The names of the schools participating in the surveys are not disclosed by the researchers in order to protect student confidentiality.

Additional information can be found at

Methodology, questions, and tables on the web at:

Radio actualities at 201.692.2846              For more information, please call 201.692.7032

SOURCE Partnership for a Drug-Free New Jersey

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.88 0.26%
FB $117.84 -0.62%
GOOG $696.19 -0.29%
TSLA $234.45 -3.00%
YHOO $36.13 -1.10%


Chart of I:DJI
DOW 17,718.72 -172.44 -0.96%
S&P 500 2,058.94 -22.49 -1.08%
NASDAQ 4,762.3140 -55.28 -1.15%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs